Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Crit Care Med ; 52(1): 92-101, 2024 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-37846935

RESUMEN

OBJECTIVES: The Berlin definition of acute respiratory distress syndrome (ARDS) was constructed for patients receiving invasive mechanical ventilation (IMV) with consideration given to issues related to reliability, feasibility, and validity. Notwithstanding, patients with acute respiratory failure (ARF) may be treated with high-flow nasal oxygen (HFNO) and may not fall within the scope of the original definition. We aimed to evaluate the predictive validity of the Berlin definition in HFNO-treated patients with COVID-19-related respiratory failure who otherwise met ARDS criteria. DESIGN: Multicenter, prospective cohort study. SETTING: Five ICUs of five centers in Argentina from March 2020 to September 2021. PATIENTS: We consecutively included HFNO-treated patients older than 18 years with confirmed COVID-19-related ARF, a Pa o2 /F io2 of less than 300 mm Hg, bilateral infiltrates on imaging, and worsening respiratory symptoms for less than 1 week. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We evaluated the predictive validity of mortality at day 28 using the area under the receiver operating characteristics curve (AUC), compared the predictive validity across subgroups, and characterized relevant clinical outcomes. We screened 1,231 patients and included 696 ARDS patients [30 (4%) mild, 380 (55%) moderate, and 286 (41%) severe]. For the study cohort, the AUC for mortality at day 28 was 0.606 (95% CI, 0.561-0.651) with the AUC for subgroups being similar to that of the overall cohort. Two hundred fifty-six patients (37%) received IMV. By day 28, 142 patients (21%) had died, of whom 81 (57%) had severe ARDS. Mortality occurred primarily in patients who were transitioned to IMV. CONCLUSIONS: The predictive validity of the Berlin ARDS definition was similar for HFNO-treated patients as compared with the original population of invasively ventilated patients. Our findings support the extension of the Berlin definition to HFNO-treated patients with ARDS.


Asunto(s)
COVID-19 , Síndrome de Dificultad Respiratoria , Insuficiencia Respiratoria , Humanos , Estudios Prospectivos , Oxígeno , Reproducibilidad de los Resultados , COVID-19/complicaciones , COVID-19/terapia , Síndrome de Dificultad Respiratoria/diagnóstico , Síndrome de Dificultad Respiratoria/terapia , Insuficiencia Respiratoria/diagnóstico , Insuficiencia Respiratoria/etiología , Insuficiencia Respiratoria/terapia
2.
Crit Care ; 26(1): 16, 2022 01 07.
Artículo en Inglés | MEDLINE | ID: mdl-34996496

RESUMEN

BACKGROUND: In patients with COVID-19-related acute respiratory failure (ARF), awake prone positioning (AW-PP) reduces the need for intubation in patients treated with high-flow nasal oxygen (HFNO). However, the effects of different exposure times on clinical outcomes remain unclear. We evaluated the effect of AW-PP on the risk of endotracheal intubation and in-hospital mortality in patients with COVID-19-related ARF treated with HFNO and analyzed the effects of different exposure times to AW-PP. METHODS: This multicenter prospective cohort study in six ICUs of 6 centers in Argentine consecutively included patients > 18 years of age with confirmed COVID-19-related ARF requiring HFNO from June 2020 to January 2021. In the primary analysis, the main exposure was awake prone positioning for at least 6 h/day, compared to non-prone positioning (NON-PP). In the sensitivity analysis, exposure was based on the number of hours receiving AW-PP. Inverse probability weighting-propensity score (IPW-PS) was used to adjust the conditional probability of treatment assignment. The primary outcome was endotracheal intubation (ETI); and the secondary outcome was hospital mortality. RESULTS: During the study period, 580 patients were screened and 335 were included; 187 (56%) tolerated AW-PP for [median (p25-75)] 12 (9-16) h/day and 148 (44%) served as controls. The IPW-propensity analysis showed standardized differences < 0.1 in all the variables assessed. After adjusting for other confounders, the OR (95% CI) for ETI in the AW-PP group was 0.36 (0.2-0.7), with a progressive reduction in OR as the exposure to AW-PP increased. The adjusted OR (95% CI) for hospital mortality in the AW-PP group ≥ 6 h/day was 0.47 (0.19-1.31). The exposure to prone positioning ≥ 8 h/d resulted in a further reduction in OR [0.37 (0.17-0.8)]. CONCLUSION: In the study population, AW-PP for ≥ 6 h/day reduced the risk of endotracheal intubation, and exposure ≥ 8 h/d reduced the risk of hospital mortality.


Asunto(s)
COVID-19 , Terapia por Inhalación de Oxígeno , Insuficiencia Respiratoria , Administración Intranasal , COVID-19/complicaciones , Humanos , Oxígeno/administración & dosificación , Terapia por Inhalación de Oxígeno/métodos , Posición Prona , Estudios Prospectivos , Insuficiencia Respiratoria/terapia , Insuficiencia Respiratoria/virología , Factores de Tiempo , Resultado del Tratamiento , Vigilia
3.
Can J Respir Ther ; 58: 151-154, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36284514

RESUMEN

Introduction: The use of high-flow nasal oxygen (HFNO) is a simple method that can reduce intubation in patients with hypoxemic acute respiratory failure (ARF). Early and prolonged prone position has demonstrated benefits on mortality in mechanically ventilated patients and on intubation in awake patients with ARF. However, strategies to achieve adherence to awake prone positioning (APP) have not been previously described. Case and outcomes: We present six patients with ARF due to COVID-19 treated with HFNO and APP. The median (p25-75) of PaFiO2 upon admission was 121 (112-175). The average duration of APP on the first day was 16 h (SD 5 h). Duration (median p25-75) in APP for the following 20 days was 13 (10-18) h/day. Several strategies such as the presence of a health care team, recreational activities, adaptation of the circadian rhythm, oral nutritional support, and analgesics were used to improve prone tolerance. None of the patients suffered from delirium, all were ambulating on discharge from the ICU and none require intubation. Conclusion: The case series presented show the feasibility of prolonged use of HFNO and APP in patients with COVID-19 and severe persistent hypoxemia and described strategies to enhance adherence.

4.
Rev. am. med. respir ; 14(3): 244-251, set. 2014. ilus, graf, tab
Artículo en Español | LILACS | ID: lil-734436

RESUMEN

Objetivo: Evaluar el estatus funcional (EF) y calidad de vida (CV) posterior al alta de terapia intensiva (UTI) en pacientes con ventilación mecánica invasiva (VM) y compararla con la población de referencia. Diseño: Cohorte prospectivo. Ámbito: UTI Sanatorio Anchorena, Buenos Aires, Argentina. Pacientes: Aquellos ingresados a UTI entre septiembre 2008 y abril 2009 con más de 24 hs de VM. Intervenciones: A los 4 meses y al año se evaluó telefónicamente la CVa través del cuestionario EQ-5D y el EF con el índice de Barthel que evalúa actividades de la vida diaria (AVD). Resultados: 77 pacientes recibieron VM, 41 mujeres (53%), mediana de edad 65 años [IC25-75% 55-77)], SAPSII 41 [28-52], días de VM 4 [2-8]. 47 pacientes sobrevivieron a la internación y fueron evaluados, 40 (85.1%) a los 4 meses y 34 (72.3%) al año. El EQ-5D a los 4 meses (mediana 0.693 IC25-75% 0.182-0.982) y al año (mediana 0.841 IC25-75% 0.493-1), se diferenciaron significativamente de la población argentina (p = 0.0004 y 0.024 respectivamente). A los 4 meses, la mitad de los pacientes presentaban dificultades en todos los dominios del EQ-5D y el 57% eran dependientes en las AVD. Al año, el 54% de los pacientes no había regresado a sus actividades previas y padecían ansiedad/depresión mientras que el 45% aún eran dependientes en las AVD. Conclusiones: Las consecuencias de la internación en UTI por una enfermedad aguda están presentes a los 4 meses y al año del alta, determinando una población con una CV significativamente menor a la no expuesta y un EF deteriorado.


Objective: To study functional status (FS) and quality of life (QoL) after discharge from intensive care unit (ICU) in patients who had > 24 hours of mechanical ventilation (MV) and to compare them with reference Argentine population. Design: Prospective cohort study. Setting: ICU at Sanatorio Anchorena, Buenos Aires , Argentina. Patients: All patients admitted to the ICU between September 2008 and April 2009 with more than 24 hours of MV. Procedures: QoL was assessed by EQ-5D and FS was evaluated through Barthel index [evaluation of daily life activities (DLA)] by telephone at 4 months and 1 year after discharge from ICU. Results: 77 patients required MV, 41 females (53%), median age 65 years (IQR 55-77), SAPSII 41 (28-52), days of MV 4 (2-8). 47 patients survived after hospitalization, 40 (85.1%) at 4 months and 34 (72.3%) one year later. The EQ-5D at 4 months (median 0.693 IQR0.182-0.982) and at 1 year (median 0.841 IQR0.493-1) of follow up were significantly lower compared with general Argentine population (p = 0.0004 and 0.024 respectively). At 4 months, half of the patients had problems in all dimensions of the Euroqol and 57% were dependent on DLA. At 1 year, 54% could not return to their previous activities, suffered from anxiety/depression and 45% were dependent on DLA. Conclusions: Effects of critical illness and ICU stay are present at 4 months and 1 year after discharge. Survivors suffer a lower quality of life and functional status than general population.


Asunto(s)
Calidad de Vida , Respiración Artificial , Cuidados Críticos
5.
Rev. am. med. respir ; 14(3): 244-251, set. 2014. ilus, graf, tab
Artículo en Español | BINACIS | ID: bin-131391

RESUMEN

Objetivo: Evaluar el estatus funcional (EF) y calidad de vida (CV) posterior al alta de terapia intensiva (UTI) en pacientes con ventilación mecánica invasiva (VM) y compararla con la población de referencia. Diseño: Cohorte prospectivo. Ambito: UTI Sanatorio Anchorena, Buenos Aires, Argentina. Pacientes: Aquellos ingresados a UTI entre septiembre 2008 y abril 2009 con más de 24 hs de VM. Intervenciones: A los 4 meses y al año se evaluó telefónicamente la CVa través del cuestionario EQ-5D y el EF con el índice de Barthel que evalúa actividades de la vida diaria (AVD). Resultados: 77 pacientes recibieron VM, 41 mujeres (53%), mediana de edad 65 años [IC25-75% 55-77)], SAPSII 41 [28-52], días de VM 4 [2-8]. 47 pacientes sobrevivieron a la internación y fueron evaluados, 40 (85.1%) a los 4 meses y 34 (72.3%) al año. El EQ-5D a los 4 meses (mediana 0.693 IC25-75% 0.182-0.982) y al año (mediana 0.841 IC25-75% 0.493-1), se diferenciaron significativamente de la población argentina (p = 0.0004 y 0.024 respectivamente). A los 4 meses, la mitad de los pacientes presentaban dificultades en todos los dominios del EQ-5D y el 57% eran dependientes en las AVD. Al año, el 54% de los pacientes no había regresado a sus actividades previas y padecían ansiedad/depresión mientras que el 45% aún eran dependientes en las AVD. Conclusiones: Las consecuencias de la internación en UTI por una enfermedad aguda están presentes a los 4 meses y al año del alta, determinando una población con una CV significativamente menor a la no expuesta y un EF deteriorado.(AU)


Objective: To study functional status (FS) and quality of life (QoL) after discharge from intensive care unit (ICU) in patients who had > 24 hours of mechanical ventilation (MV) and to compare them with reference Argentine population. Design: Prospective cohort study. Setting: ICU at Sanatorio Anchorena, Buenos Aires , Argentina. Patients: All patients admitted to the ICU between September 2008 and April 2009 with more than 24 hours of MV. Procedures: QoL was assessed by EQ-5D and FS was evaluated through Barthel index [evaluation of daily life activities (DLA)] by telephone at 4 months and 1 year after discharge from ICU. Results: 77 patients required MV, 41 females (53%), median age 65 years (IQR 55-77), SAPSII 41 (28-52), days of MV 4 (2-8). 47 patients survived after hospitalization, 40 (85.1%) at 4 months and 34 (72.3%) one year later. The EQ-5D at 4 months (median 0.693 IQR0.182-0.982) and at 1 year (median 0.841 IQR0.493-1) of follow up were significantly lower compared with general Argentine population (p = 0.0004 and 0.024 respectively). At 4 months, half of the patients had problems in all dimensions of the Euroqol and 57% were dependent on DLA. At 1 year, 54% could not return to their previous activities, suffered from anxiety/depression and 45% were dependent on DLA. Conclusions: Effects of critical illness and ICU stay are present at 4 months and 1 year after discharge. Survivors suffer a lower quality of life and functional status than general population.(AU)

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA